['diabetes mellitus, type 2']
['ticagrelor 60 mg', 'ticagrelor placebo']

        Inclusion Criteria:

        Men or women ≥50 years of age with type 2 diabetes mellitus on treatment with a glucose
        lowering medication since at least 6 months, and either documented coronary artery
        occlusive disease or previous revascularization of a coronary artery.

        Key Exclusion Criteria:

        History of myocardial infarction or any stroke; planned treatment with agents inhibiting
        blood clotting; planned use of ASA/Aspirin at doses above 150 mg daily; planned coronary,
        cerebrovascular, or peripheral arterial revascularization; patients with known bleeding
        disorders and patients who need chronic oral anticoagulant therapy or chronic
        low-molecular-weight heparin; history of intracranial bleeding at any time, or a history of
        bleeding from the gastrointestinal tract within the last 6 months or a major surgery within
        the last 30 days; patients with known severe liver disease or with kidney failure requiring
        dialysis
      